ALK as a common target for the pathogenesis and therapy in lymphoma, lung carcinoma and neuroblastoma

Project Information

LUNELY

Grant agreement ID: 242965

Project closed

Start date 1 November 2009

End date 30 April 2014

Funded under

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 1 010 000,00

EU contribution € 1 010 000,00

Coordinated by

UNIVERSITA DEGLI STUDI DI TORINO
Italy